FibroGen Appoints Suzanne Blaug to Board of Directors

NEXT STORY
American BriVision Announces Positive Phase II (Part 2) Results for ABV-1504 for Major Depressive Disorder
PREV STORY
Agios Announces the Planned Retirement of Chief Scientific Officer, Scott Biller, Ph.D., Effective December 31, 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Exagen Featured in Eight Scientific Presentations at The 2018 ACR/ARHP Annual Meeting in Chicago, IL

Leading immunology laboratory continues strides with first ever economic impact data for AVISE LupusALBUQUERQUE, ...

author_avatar
NASDAQ Market News

EPIRUS Biopharmaceuticals Reports Third Quarter 2015 Financial Results & Provides Business Update

BOSTON, Nov. 16, 2015 (GLOBE NEWSWIRE) -- EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Life Foundation Offers 2016 Life Grants to Assist Those with Infertility

CHICAGO, April 12, 2016 (GLOBE NEWSWIRE) -- The Kevin J. Lederer Life Foundation, a ...

author_avatar
NASDAQ Market News